UBS: Downgraded the Treace Medical Concepts (TMCI.US) rating from buy to neutral, and adjust the target price from $16.00 to $6.50.
瑞银：下调Treace Medical Concepts(TMCI.US)评级，由买入调整至中性评级, 目标价由16.00美元调整至6.50美元。
UBS: Downgraded the Treace Medical Concepts (TMCI.US) rating from buy to neutral, and adjust the target price from $16.00 to $6.50.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated